Genemarkers has developed ex vivo tissue models that mimic key components of atopic dermatitis (AD) and psoriasis to facilitate...
Ex Vivo Tissue Models for Atopic Dermatitis and Psoriasis
read more
News And EVENTS
Stay up to date with our latest news and see where you can find us next.
Mitigating Adverse Drug Events in Polypharmacy with PGx
What are ADEs and Polypharmacy? An adverse drug event, or ADE, occurs when a person is harmed due to a prescription medication. This can...
A Reproducible Method for Assessing the Effects of Blue Light Using in vitro Human Skin Tissues
Genemarkers LLC is pleased to announce the publication of the paper, Reproducible method for assessing the effects of blue light...
Genemarkers Pharmacogenomic (PGx) Testing Panels Earn Approval from New York State – CLEP
Genemarkers is proud to announce today that the New York State Department of Health Clinical Laboratory Evaluation Program...
Introducing Genemarkers’ Updated Pharmacogenomic (PGx) Panels
Genemarkers has been providing high-quality clinical genetic testing since 2014. As a pioneer in the pharmacogenomic (PGx)...
New Legislation Seeks to Reduce Adverse Drug Events Through Pharmacogenomic Testing
The National Action Plan for Adverse Drug Event Prevention An adverse drug event (ADE) is defined as harm that results from a medication...
Genemarkers Receives Pure Michigan Business Connect Grant to Begin COVID-19 Testing
Genemarkers is honored to be one of 12 small businesses and nonprofits selected to receive the Pure Michigan Business Connect...
Contact the GENEMARKERS Team
Have questions? Interested in learning more about how Genemarkers can help? Fill out the form below and a member of our team will reach out shortly.